Cargando…

Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure

OBJECTIVES: We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. DESIGN: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alladina, Jehan W., Giacona, Francesca L., White, Emma B., Brait, Kelsey L., Abe, Elizabeth A., Michelhaugh, Sam A., Hibbert, Kathryn A., Januzzi, James L., Thompson, B. Taylor, Cho, Josalyn L., Medoff, Benjamin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245109/ https://www.ncbi.nlm.nih.gov/pubmed/34235459 http://dx.doi.org/10.1097/CCE.0000000000000480

Ejemplares similares

Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study
por: Ziehr, David R., et al.
Publicado: (2020)

Reply to Yaroshetskiy et al.: Acute Respiratory Distress Syndrome in COVID-19: Do All These Patients Definitely Require Intubation and Mechanical Ventilation?
por: Ziehr, David R., et al.
Publicado: (2020)

Respiratory Physiology of Prone Positioning With and Without Inhaled Nitric Oxide Across the Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Severity Spectrum
por: Ziehr, David R., et al.
Publicado: (2021)

Reply to Epelbaum: Standards and Stereotypes in COVID-19
por: Ziehr, David R., et al.
Publicado: (2020)

Finding a Needle in a Haystack: Proteomics in Heart Failure
por: Michelhaugh, Sam A., et al.
Publicado: (2020)

Serial laboratory biomarkers are associated with ICU outcomes in patients hospitalized with COVID-19
por: Wang, Xinan, et al.
Publicado: (2023)

Soluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis
por: Yang, Hyun Suk, et al.
Publicado: (2016)

Tumorigenicity of acridine orange.
por: Van Duuren, B. L., et al.
Publicado: (1969)

A randomized trial of an intervention to improve resident-fellow teaching interactions on the wards
por: Gupta, Shruti, et al.
Publicado: (2016)

Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
por: Huang, Dong-Hui, et al.
Publicado: (2016)

Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure
por: Öncel, Can Ramazan
Publicado: (2018)

Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022)

Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung
por: Faustino, Lucas D., et al.
Publicado: (2020)

Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity‐2
por: Gerber, Yariv, et al.
Publicado: (2017)

Snail depletes the tumorigenic potential of glioblastoma
por: Savary, K, et al.
Publicado: (2013)

Allergic Non-Asthmatic Adults Have Regional Pulmonary Responses to Segmental Allergen Challenge
por: Kelly, Vanessa J., et al.
Publicado: (2015)

Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide
por: Riccardi, Mauro, et al.
Publicado: (2023)

The free cytoplasmic calcium concentration of tumorigenic and non-tumorigenic human somatic cell hybrids.
por: Banyard, M. R., et al.
Publicado: (1985)

Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
por: Chen, Dongqing, et al.
Publicado: (2023)

Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review
por: Hariri, Lida P., et al.
Publicado: (2021)

Pro‐tumorigenic Effects of Transforming Growth Factor Beta 1 in Canine Osteosarcoma
por: Portela, R.F., et al.
Publicado: (2014)

Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure
por: Gül, İbrahim, et al.
Publicado: (2017)

Poised with purpose: Cell plasticity enhances tumorigenicity
por: Marjanovic, Nemanja D, et al.
Publicado: (2013)

Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines
por: Jimenez, Rosa H., et al.
Publicado: (2009)

Prolonged Prone Position Ventilation Is Associated With Reduced Mortality in Intubated COVID-19 Patients
por: Okin, Daniel, et al.
Publicado: (2023)

Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
por: Glabman, Raisa A., et al.
Publicado: (2022)

Derivation and External Validation of a High‐Sensitivity Cardiac Troponin–Based Proteomic Model to Predict the Presence of Obstructive Coronary Artery Disease
por: McCarthy, Cian P., et al.
Publicado: (2020)

Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study
por: Rezar, Richard, et al.
Publicado: (2021)

Soluble suppression of tumorigenicity 2 associated with fulminant myocarditis in children: A retrospective observational study
por: Hou, Wenquan, et al.
Publicado: (2023)

Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver transplant renal outcomes
por: Moon, Jong Joo, et al.
Publicado: (2023)

Soluble Suppression of Tumorigenicity-2 as a Candidate Prognostic Marker for Stroke: A Systematic Review
por: Ahmadzadeh, Koohyar, et al.
Publicado: (2023)

Serum soluble suppression of tumorigenicity-2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect
por: Pratama, Reza S., et al.
Publicado: (2020)

MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity
por: Samaraweera, Leleesha, et al.
Publicado: (2014)

Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis
por: Zhang, Yan, et al.
Publicado: (2021)

Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis
por: Guo, Guangying, et al.
Publicado: (2021)

Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation
por: Tan, Ruopeng, et al.
Publicado: (2021)

Soluble suppression of tumorigenicity 2 associated with atrial fibrillation detected after stroke: A retrospective study
por: Hou, Wenquan, et al.
Publicado: (2023)

CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic
por: Marshall, A D, et al.
Publicado: (2017)

A High-Throughput, High-Containment Human Primary Epithelial Airway Organ-on-Chip Platform for SARS-CoV-2 Therapeutic Screening
por: Fisher, Christine R., et al.
Publicado: (2023)

Dedifferentiation of committed epithelial cells into stem cells in vivo
por: Tata, Purushothama Rao, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a6665nr9p379ir8d8pvh801bca